Trinity Biotech ADR buy StockNews.com
Start price
12.02.24
/
50%
€0.52
Target price
12.02.25
-
Performance (%)
-20.77%
Price
22.02.24
€0.41
Summary
This prediction is currently active. The prediction for Trinity Biotech ADR disappoints with a performance of -20.77%. This prediction currently runs until 12.02.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Trinity Biotech ADR | - | - |
iShares Core DAX® | -3.429% | 3.133% |
iShares Nasdaq 100 | -6.121% | -1.433% |
iShares Nikkei 225® | -7.364% | 1.018% |
iShares S&P 500 | -4.366% | 0.247% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat